<DOC>
	<DOCNO>NCT01669772</DOCNO>
	<brief_summary>DA-9701 new prokinetic agent formulate Pharbitis Seed Corydalis Tuber . These plant use oriental traditional medicine treatment gastrointestinal malady . In stage 3 trial , ' efficacy compare itopride functional dyspepsia patient prove comparable safety efficacy . However , ' exact effect gastrointestinal motility completely elucidate . This study study effect DA-9701 healthy adult gastrointestinal tract .</brief_summary>
	<brief_title>Study Effects DA-9701 Gastrointestinal Motility Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy adult either sex , least 20 year age Having abdominal discomfort pain No disease diagnose screen gastroduodenoscopy Having give voluntary write consent Currently participate participate another drug trial within four week trial start . Women childbearing age either pregnant , breastfeed proper contraceptive method . A history surgery may affect gastrointestinal motility . Subjects gastrointestinal bleeding , mechanical obstruction perforation . Subjects irritable bowel syndrome inflammatory bowel disease . Subjects serious condition involve liver , kidney , heart , lung endocrinology system . Psychiatric disease patient , substance abuse subject alcohol drug . Subjects take drug may affect study outcome antibiotic , corticosteroid NSAIDS within 1 month motility agent , H2 receptor blocker , proton pump inhibitor , anticholinergic , erythromycin antipsychotic within 2 week . Other reason investigator considers valid .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>